Mechanism of protective effect of prostaglandin E in murine hepatitis virus strain 3 infection: effects on macrophage production of tumour necrosis factor, procoagulant activity and leukotriene B4.
Sinclair
S
S
Department of Medicine, University of Toronto, Canada.
Abecassis
M
M
Wong
P Y
PY
Romaschin
A
A
Fung
L S
LS
Levy
G
G
D015064:16,16-Dimethylprostaglandin E2 / Q000494:pharmacology*; D000818:Animals; D015232:Dinoprostone / Q000096:biosynthesis*; D004198:Disease Susceptibility; D005169:Factor VIII / Q000096:biosynthesis*; D006524:Hepatitis, Viral, Animal / Q000503:physiopathology*; D007113:Immunity, Innate / Q000502:physiology; D066298:In Vitro Techniques; D007700:Kinetics; D007975:Leukotriene B4 / Q000096:biosynthesis*; D008264:Macrophages / Q000187:drug effects / Q000382:microbiology / Q000502:physiology*; D051379:Mice; D008805:Mice, Inbred A; D008807:Mice, Inbred BALB C; D008954:Models, Biological; D006517:Murine hepatitis virus / Q000254:growth & development* / Q000472:pathogenicity; D013045:Species Specificity; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D014409:Tumor Necrosis Factor-alpha; D007975:Leukotriene B4; D005169:Factor VIII; D015232:Dinoprostone; D015064:16,16-Dimethylprostaglandin E2